– CJC-1295 with DAC (Drug Affinity Complex)

Price range: $75.00 through $130.00

Product Classification

Classified as a GHRH analogue with extended half-life

Description

CJC-1295 with DAC is a growth hormone releasing hormone (GHRH) analogue engineered for prolonged half-life via drug affinity complex (DAC) technology.
Research examines endocrine release profiles, IGF-1 modulation, and pulsatile GH signaling durability.

Specifications

  • Molecular Type: GHRH analogue with DAC modification
  • Mechanism: GH/IGF-1 axis modulation

Research Notes

  • GH Signaling: enhanced pulse amplitude and frequency reported in research contexts
  • IGF-1: increases observed in preclinical hormonal models.
  • Half-Life Extension: DAC allows extended exposure windows.
  • Endocrine Modulation: interest in metabolic, body composition, and recovery models.
Regulatory Statement

For research use only. Not for human or animal consumption.

Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent disease

SKU: N/A Category:

Additional information

Strength

2mg, 5mg

Reviews

There are no reviews yet.

Be the first to review “– CJC-1295 with DAC (Drug Affinity Complex)”

Your email address will not be published. Required fields are marked *